Improving the Safety of Blood Products (Packaged Red Blood Cell) through Anti- Bacterial Activity of Novel Synthesized Chalcone Against Isolated S. epidermidis and S. aureus

Authors

DOI:

https://doi.org/10.35882/ijahst.v2i6.174

Keywords:

anti-bacterial activity, blood products, novel chalcone synthesis

Abstract

Bacterial contamination in blood product was still a problem in Indonesia. Various studies to improve the safety of blood product by inhibiting the bacterial growth in blood product was developed. Chalcone, is one of the natural compounds that has ability to inhibit the bacterial growth, so it can be possible to use that compound for anti-bacterial use in the future. This study aim is to evaluate the anti-bacterial activity of novel synthesis chalcone (E)-1-(4-hydroxyphenyl)-3-phenylprop-2-en-1-one against S. epidermidis and S. aureus isolated from packed red cell blood product. A novel chalcone was synthesized by Claisen-Schmidt Methods while anti-bacterial activity test was done by Agar Diffusion Methods. Chalcone that has been synthesized then characterized by Fourier Transform Infra-Red (FTIR) Methods and Gas Chromatography – Mass Spectrometry (GC-MS). Chalcone was synthesized through a condensation reaction between an aldehyde (benzaldehyde) and ketone (acetophenone) with NaOH as alkaline catalyst. The results from sedimentary analysis using FTIR showed an absorption of the C=C group in the typical medium of chalcone compounds, at the wave number of 1516.96 cm-1. The results of GC-MS characterization resulted a GC chromatogram with one peak with time of retention (tR) 19.68 minutes and relative purity 100%. MS mass spectrum shows that the molecular ion (M+) of this compound was detected at 224 which equivalents to the molecular weight of the chalcone compound. Anti-bacterial test showed that the synthetic chalcone compound with 5% concentration had an inhibitory ability of 56.02% on S. epidermidis and 54.10% on S. aureus, while 2.5% chalcone concentration had an inhibitory ability of 29.17% on S. epidermidis and 50.45% on S. aureus, and 1.25% chalcone concentration had inhibitory ability 0% on S. epidermidis and 37.27% on S. aureus.

Downloads

Download data is not yet available.

References

Y. A. Park and M. E. Brecher, “Bacterial Contamination of Blood Products,” Ross. Princ. Transfus. Med. Fourth Ed., pp. 773–790, 2009, doi: 10.1002/9781444303513.ch49.

W. Tsegaye, A. Bitew, and A. Gize, “Bacterial Contamination and Susceptibility Pattern Among Blood and Blood Components Using Divergent and Non-Divergent Collection Methods at Armed Forces Comprehensive Specialized Hospital, Addis Ababa, Ethiopia,” Infect. Drug Resist., vol. 15, no. March, pp. 1677–1686, 2022, doi: 10.2147/IDR.S360515.

G. B. M. Aloysius, B. Joel, R. Apecu, B. Yap II, and F. Byarugaba, “Bacterial Contamination of Blood and Blood Products at Mbarara Regional Blood Bank in Rural South Western Uganda,” Adv. Infect. Dis., vol. 03, no. 03, pp. 205–209, 2013, doi: 10.4236/aid.2013.33030.

C. E. S. Nogueira et al., “Crystal structure, FT-Raman and FTIR spectra and DFT calculations of chalcone (2E)-1-(4-aminophenyl)-3-(furan-2- yl)prop-2-en-1-one monohydrate,” J. Mol. Struct., vol. 1212, 2020, doi: 10.1016/j.molstruc.2020.128141.

B. Salehi et al., “Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence,” Front. Pharmacol., vol. 11, no. January, 2021, doi: 10.3389/fphar.2020.592654.

K. S. Kumar, V. Siddaiah, J. D. Lilakar, and A. Ganesh, “An efficient continuous-flow synthesis and evaluation of antimicrobial activity of novel 1,2,3-Triazole-Furan hybrid chalcone derivatives,” Chem. Data Collect., vol. 28, p. 100457, 2020, doi: 10.1016/j.cdc.2020.100457.

J. E. Rocha et al., “Antibacterial and antibiotic modifying activity, ADMET study and molecular docking of synthetic chalcone (E)-1-(2- hydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)prop-2-en-1-one in strains of Staphylococcus aureus carrying NorA and MepA efflux pumps,” Biomed. Pharmacother., vol. 140, no. May, 2021, doi: 10.1016/j.biopha.2021.111768.

B. Zhang et al., “Chalcone attenuates Staphylococcus aureus Virulence by Targeting Sortase A and Alpha-Hemolysin,” Front. Microbiol., vol. 8, no. SEP, 2017, doi: 10.3389/fmicb.2017.01715.

W. Sepvianti and B. S. C. Kusumaningrum, “Synthesis and Antibacterial Activities Test of Chalcone (E)-3-(4- (Dimethylamino)Phenyl)-1-Phenylprop-2-En-1-One Against Bacteria Contaminant Blood Products,” J. Heal., vol. 8, no. 2, pp. 75–84, 2021.

A. K. Jumaa, H. H. J. Al-Shammari, and Z. R. Qasim, “The Frequency and Spectrum of Bacterial Contamination of Packed Red Blood Cells and Platelet Concentrate Units from a Sample of Iraqi Blood Donors,” ASM Sci. J., vol. 15, no. May, pp. 1–4, 2021, doi: 10.32802/ASMSCJ.2021.749.

M. M. Brown and A. R. Horswill, “Staphylococcus epidermidis-Skin friend or foe?,” PLoS Pathog., vol. 16, no. 11, pp. 1–6, 2020, doi:

1371/JOURNAL.PPAT.1009026.

M. Agzie, S. Niguse, E. Tsegay, G. Kahsay, and M. A. Mahmud, “Bacterial contaminants of stored blood and blood components ready for transfusion at blood banks in Mekelle, Northern Ethiopia,” BMC Res. Notes, vol. 12, no. 1, pp. 1–6, 2019, doi: 10.1186/s13104-019- 4217-0.

M. Attarde, A. Vora, A. Varghese, and Y. Kachwala, “Synthesis and evaluation of chalcone derivatives for its alpha amylase inhibitory activity,” Org. Chem. an Indian J., vol. 10, no. 5, pp. 192–204, 2014.

A. M. Asiri and S. A. Khan, “Synthesis and anti-bacterial activities of a bis-chalcone derived from thiophene and its bis-cyclized products,” Molecules, vol. 16, no. 1, pp. 523–531, 2011, doi: 10.3390/molecules16010523.

N. A. A. Elkanzi, H. Hrichi, R. A. Alolayan, W. Derafa, F. M. Zahou, and R. B. Bakr, “Synthesis of Chalcones Derivatives and Their Biological Activities: A Review,” ACS Omega, vol. 7, no. 32, pp. 27769–27786, 2022, doi: 10.1021/acsomega.2c01779.

I. Ikhtiarudina ’ et al., “Jurnal Kimia Sains dan Aplikasi Journal of Scientific and Applied Chemistry Microwave-assisted synthesis of i-( 4-hydroxyphenyl)-3-( 4-methoxyphenyl)prop-2-en-i-one and its activities as an antioxidant, sunscreen, and antibacterial,” J. Kim. Sains dan Apl., vol. 23, no. 2, pp. 51–60, 2020, [Online]. Available: http://ejournal.undip.ac.id/index.php/ksa

G. D. Yadav and D. P. Wagh, “Claisen-Schmidt Condensation using Green Catalytic Processes: A Critical Review,” ChemistrySelect, vol. 5, no. 29, pp. 9059–9085, 2020, doi: 10.1002/slct.202001737.

A. F. M. M. Rahman, R. Ali, Y. Jahng, and A. A. Kadi, “A facile solvent free claisen-schmidt reaction: Synthesis of α,α’-bis-(Substituted- benzylidene)cycloalkanones and α,α’-bis-(Substituted- alkylidene)cycloalkanones,” Molecules, vol. 17, no. 1, pp. 571–583, 2012, doi: 10.3390/molecules17010571.

S. Dan and U. J. I. Antibakteri, “ety.birink,” vol. 4, no. 2, pp. 103–108, 2015.

W. Dan and J. Dai, “Recent developments of chalcones as potential antibacterial agents in medicinal chemistry,” Eur. J. Med. Chem., vol. 187, p. 111980, 2020, doi: 10.1016/j.ejmech.2019.111980.

L. Gasque, J. R. Álvarez-Idaboy, M. Flores-Álamo, Ó. Guzmán- Méndez, and J. M. Campos-Cerón, “Theoretical and experimental study demonstrates kinetic control in chalcone-flavanone transformation of naphthalene derivatives,” J. Mol. Struct., vol. 1157, pp. 631–637, 2018, doi: 10.1016/j.molstruc.2017.12.078.

W. Sepvianti and S. B. C. Kusumaningrum, “Antibacterial Assay of 2’- Hydroxy-4’,6’,4-Trimethoxychalcone and 4-Methoxychalcone Against Gram Positive and Gram Negative Bacteria,” J. Ris. Kesehat., vol. 8, no. 2, p. 17, 2019, doi: 10.31983/jrk.v8i2.5378.

H. Nmr, “Ournal of,” vol. 29, no. 2, pp. 454–456, 2017.

M. Khera et al., “Vancomycin-resistant Gram-positive bacterial endophthalmitis: Epidemiology, treatment options, and outcomes,” J. Ophthalmic Inflamm. Infect., vol. 3, no. 1, pp. 1–4, 2013, doi: 10.1186/1869-5760-3-46.

S. M. Lemon and C. M. Walker, “乳鼠心肌提取HHS Public Access,” Physiol. Behav., vol. 14, no. 9, pp. 2065–2070, 2019, doi: 10.1021/acschembio.9b00565.A.

T. Yang, Y. Tal-Gan, A. E. Paharik, A. R. Horswill, and H. E. Blackwell, “Structure-Function Analyses of a Staphylococcus epidermidis Autoinducing Peptide Reveals Motifs Critical for AgrC- type Receptor Modulation,” ACS Chem. Biol., vol. 11, no. 7, pp. 1982– 1991, 2016, doi: 10.1021/acschembio.6b00120.

G. Méric et al., “Disease-associated genotypes of the commensal skin bacterium Staphylococcus epidermidis,” Nat. Commun., vol. 9, no. 1, pp. 1–11, 2018, doi: 10.1038/s41467-018-07368-7.

T. Moreira Osório et al., “Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus,” Bioorganic Med. Chem. Lett., vol. 22, no. 1, pp. 225–230, 2012, doi: 10.1016/j.bmcl.2011.11.059.

L. M. Rezende-Júnior et al., “Chalcones isolated from Arrabidaea brachypoda flowers as inhibitors of nora and mepa multidrug efflux pumps of Staphylococcus aureus,” Antibiotics, vol. 9, no. 6, pp. 1–12, 2020, doi: 10.3390/antibiotics9060351.

K. V. Sashidhara et al.,“Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus,” ACS Med.Chem.Lett., vol. 6,no.7,pp.809–813, 2015,doi: 10.1021/acsmedchemlett.5b00169.

Downloads

Published

2022-12-09

How to Cite

[1]
A. Rahman, W. . Sepvianti, S. B. C. . Kusumaningrum, A. . Sari, and M. N. . Salleh, “Improving the Safety of Blood Products (Packaged Red Blood Cell) through Anti- Bacterial Activity of Novel Synthesized Chalcone Against Isolated S. epidermidis and S. aureus”, International Journal of Advanced Health Science and Technology, vol. 2, no. 6, pp. 377–384, Dec. 2022.

Issue

Vol. 2 No. 6 (2022): December

Section

Medical Engineering and Technology

License

Copyright (c) 2022 Aulia Rahman

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlikel 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).